Fufang Anwei Jiaonang (复方氨维胶囊)复方氨维胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 无锡正东药业有限公司Chinese legal name: 无锡正东药业有限公司
主要成分Active Ingredients
- 维生素BWeisheng Su
- 氨基酸等Anji Suandeng
药物知识说明
维生素B是一种在国家药监局注册认定的药品。该药品含有相关活性成分。
该药品关联的活性成分包括：氨基酸等Anji Suandeng、维生素b。这些成分信息来自国家药监局数据库。
您可以探索含有相同成分的其他药品：氨基酸等-b87b7eff成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 复方氨维胶囊) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.
Active ingredients associated with this product: 氨基酸等Anji Suandeng.
Explore other medicines containing the same ingredient: 氨基酸等 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 复方氨维胶囊Recorded Chinese name: 复方氨维胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 30粒30 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 无锡正东药业有限公司Chinese legal name: 无锡正东药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H32020001
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H32020001
Manufacturer
Chinese legal name: 无锡正东药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H32020001
生产企业
无锡正东药业有限公司(国产)
适应症
成人滋养强壮、体质虚弱、机体疲劳、患病期间或愈后、胃肠障碍、营养不良、发热性消耗性疾病、孕妇及产妇等的营养补充；儿童发育期的营养补充，小儿偏食造成的营养不良，患病期间或愈后，胃肠障碍，发热性消耗性疾病，体质虚弱；有助于增强人体免疫能力。用于各种疾病所致的低蛋白血症的辅助治疗，如：慢性肝病、肝硬化或肾病所致的低蛋白症；外科手术后或恶性肿瘤所致负氧平衡和低蛋白血症。
用法用量
口服，每次1～2粒，每日2次；小儿每日1～3粒，或遵医嘱。
不良反应
尚未见不良反应报道。
禁忌
1、对本品过敏者禁用。
2、未满7岁的婴幼儿禁用。
注意事项
1.儿童须在监护人指导监督下服用。
2.若长期服药后无明显症状改善，请咨询医师。
3.请放在儿童触不到的地方。
4.服用本品后尿液变黄是由于药品中含维生素B2的缘故。
贮藏
密封，避光，在干燥处保存。
规格
30粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.